Hybridoma Development Studies and Antibody Production
Awarded Award Notice Posted
- Solicitation number
- HT942525D0002
- Agency
- Defense Health Agency Department of Defense
- Awarded
- to Kemp Proteins, LLC
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- HT942525D0002 Federal IDV award
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Maryland 21704, United States
- Points of contact
-
- Emily K. O'Hara emily.k.ohara.civ@health.mil (301) 619-9599
- Shelley Wallace shelley.a.wallace2.civ@health.mil (301) 619-3152
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency awarded a firm fixed price contract valued at $864,362.00 to Kemp Proteins, LLC on July 9, 2025, for hybridoma development studies and antibody production services. The contract, designated HT942525D0002, is classified as a non-personal services agreement that will support the United States Army Medical Research Institute of Infectious Diseases. This award was set aside for small businesses and involves specialized biotechnology services for developing hybridomas and producing antibodies for military medical research purposes.
Notice text
Kemp Proteins, LLC received a Firm Fix Price award for a non-personal service(s) contract to provide hybridoma development studies and antibody production in support of United States Army Medical Research Institute of Infectious Diseases.
Awarded contract HT942525D0002 to KEMP PROTEINS, LLC for 864362.00 on 2025-07-09.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Hybridoma Development Studies and Antibody Production | Award Notice | |
| Hybridoma Development Studies and Antibody Production | Solicitation | |
| Hybridoma Development Studies | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity